Journal of Infection
Volume 60, Issue 3 , Pages 200-208, March 2010

Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996–2006

  • Caroline L. Trotter

      Affiliations

    • Department of Social Medicine, University of Bristol, Canynge Hall, Whatley Road, Bristol BS8 2PS, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 117 928 7220.
  • ,
  • Pauline Waight

      Affiliations

    • Immunisation Department, Health Protection Agency Centre for Infections, Colindale, London, UK
  • ,
  • Nick J. Andrews

      Affiliations

    • Statistics, Modelling and Economics Department, Health Protection Agency Centre for Infections, Colindale, London, UK
  • ,
  • Mary Slack

      Affiliations

    • Respiratory and Systemic Infection Laboratory, Health Protection Agency Centre for Infections, Colindale, London, UK
  • ,
  • Androulla Efstratiou

      Affiliations

    • Respiratory and Systemic Infection Laboratory, Health Protection Agency Centre for Infections, Colindale, London, UK
  • ,
  • Robert George

      Affiliations

    • Respiratory and Systemic Infection Laboratory, Health Protection Agency Centre for Infections, Colindale, London, UK
  • ,
  • Elizabeth Miller

      Affiliations

    • Immunisation Department, Health Protection Agency Centre for Infections, Colindale, London, UK

Accepted 15 December 2009. published online 04 January 2010.

Summary 

Objective

To describe the epidemiology of invasive pneumococcal disease (IPD) in England & Wales in the pre-conjugate vaccine era.

Methods

We analysed reports of culture-confirmed IPD submitted to the national surveillance system between July 1996 and June 2006.

Results

The incidence of IPD was 10 per 100,000 overall, and increased over time. The typical pattern of IPD by age was observed, with the highest incidence in young children and older adults. There was little change in IPD incidence in the elderly, despite the widespread use of 23-valent pneumococcal polysaccharide vaccines since 2003. The distribution of serotypes changed over time; notably the proportion of cases caused by serotype 14 decreased, and the proportion due to serotype 1 increased. The incidence of meningitis was 0.6 per 100,000 overall, and as a proportion of all IPD cases was most common in children under 1 year of age (30%). Particular serotypes were significantly associated with a presentation of meningitis, after controlling for age and year, and the case:carrier ratio varied markedly by serotype.

Conclusions

This paper provides a baseline for evaluating the impact of 7-valent pneumococcal conjugate vaccines, introduced in September 2006. Ongoing high-quality laboratory-based surveillance of IPD in all age groups is essential.

Keywords: Streptococcus pneumoniae, Invasive pneumococcal disease, Epidemiology, Meningitis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0163-4453(09)00392-2

doi:10.1016/j.jinf.2009.12.008

Journal of Infection
Volume 60, Issue 3 , Pages 200-208, March 2010